Literature DB >> 24022593

Ligand- and cell-dependent determinants of internalization and cAMP modulation by delta opioid receptor (DOR) agonists.

Iness Charfi, Karim Nagi, Ouissame Mnie-Filali, Dominic Thibault, Gianfranco Balboni, Peter W Schiller, Louis-Eric Trudeau, Graciela Pineyro.   

Abstract

Signaling bias refers to G protein-coupled receptor ligand ability to preferentially activate one type of signal over another. Bias to evoke signaling as opposed to sequestration has been proposed as a predictor of opioid ligand potential for generating tolerance. Here we measured whether delta opioid receptor agonists preferentially inhibited cyclase activity over internalization in HEK cells. Efficacy (τ) and affinity (KA) values were estimated from functional data and bias was calculated from efficiency coefficients (log τ/KA). This approach better represented the data as compared to alternative methods that estimate bias exclusively from τ values. Log (τ/KA) coefficients indicated that SNC-80 and UFP-512 promoted cyclase inhibition more efficiently than DOR internalization as compared to DPDPE (bias factor for SNC-80: 50 and for UFP-512: 132). Molecular determinants of internalization were different in HEK293 cells and neurons with βarrs contributing to internalization in both cell types, while PKC and GRK2 activities were only involved in neurons. Rank orders of ligand ability to engage different internalization mechanisms in neurons were compared to rank order of E max values for cyclase assays in HEK cells. Comparison revealed a significant reversal in rank order for cyclase E max values and βarr-dependent internalization in neurons, indicating that these responses were ligand-specific. Despite this evidence, and because kinases involved in internalization were not the same across cellular backgrounds, it is not possible to assert if the magnitude and nature of bias revealed by rank orders of maximal responses is the same as the one measured in HEK cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24022593      PMCID: PMC3952036          DOI: 10.1007/s00018-013-1461-7

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  58 in total

1.  Bioluminescence resonance energy transfer assays reveal ligand-specific conformational changes within preformed signaling complexes containing delta-opioid receptors and heterotrimeric G proteins.

Authors:  Nicolas Audet; Céline Galés; Elodie Archer-Lahlou; Marc Vallières; Peter W Schiller; Michel Bouvier; Graciela Pineyro
Journal:  J Biol Chem       Date:  2008-04-01       Impact factor: 5.157

2.  Introduction: Recommendations for the diagnosis, assessment, and treatment of neuropathic pain.

Authors:  Robert H Dworkin
Journal:  Am J Med       Date:  2009-10       Impact factor: 4.965

3.  Granulocyte chemotaxis and disease expression are differentially regulated by GRK subtype in an acute inflammatory arthritis model (K/BxN).

Authors:  Teresa K Tarrant; Rishi R Rampersad; Denise Esserman; Lisa R Rothlein; Peng Liu; Richard T Premont; Robert J Lefkowitz; David M Lee; Dhavalkumar D Patel
Journal:  Clin Immunol       Date:  2008-07-26       Impact factor: 3.969

Review 4.  The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence.

Authors:  Lene Martini; Jennifer L Whistler
Journal:  Curr Opin Neurobiol       Date:  2007-12-18       Impact factor: 6.627

Review 5.  Physiological and pharmacological implications of beta-arrestin regulation.

Authors:  Cullen L Schmid; Laura M Bohn
Journal:  Pharmacol Ther       Date:  2008-12-06       Impact factor: 12.310

6.  Post-endocytic fates of delta-opioid receptor are regulated by GRK2-mediated receptor phosphorylation and distinct beta-arrestin isoforms.

Authors:  Xiaoqing Zhang; Feifei Wang; Xiaoqing Chen; Yuejun Chen; Lan Ma
Journal:  J Neurochem       Date:  2008-04-17       Impact factor: 5.372

7.  G protein independent phosphorylation and internalization of the delta-opioid receptor.

Authors:  Faye A Bradbury; Jennifer C Zelnik; John R Traynor
Journal:  J Neurochem       Date:  2009-04-01       Impact factor: 5.372

8.  Site-specific phosphorylation of CXCR4 is dynamically regulated by multiple kinases and results in differential modulation of CXCR4 signaling.

Authors:  John M Busillo; Sylvain Armando; Rajarshi Sengupta; Olimpia Meucci; Michel Bouvier; Jeffrey L Benovic
Journal:  J Biol Chem       Date:  2010-01-04       Impact factor: 5.157

9.  In vivo delta opioid receptor internalization controls behavioral effects of agonists.

Authors:  Amynah A A Pradhan; Jérôme A J Becker; Grégory Scherrer; Petra Tryoen-Toth; Dominique Filliol; Audrey Matifas; Dominique Massotte; Claire Gavériaux-Ruff; Brigitte L Kieffer
Journal:  PLoS One       Date:  2009-05-01       Impact factor: 3.240

10.  Src promotes delta opioid receptor (DOR) desensitization by interfering with receptor recycling.

Authors:  Elodie Archer-Lahlou; Nicolas Audet; Mohammad Gholi Amraei; Karine Huard; Mélanie Paquin-Gobeil; Graciela Pineyro
Journal:  J Cell Mol Med       Date:  2008-03-19       Impact factor: 5.310

View more
  20 in total

1.  Endocytic profiles of δ-opioid receptor ligands determine the duration of rapid but not sustained cAMP responses.

Authors:  Hanieh Bagheri Tudashki; Derek N Robertson; Peter W Schiller; Graciela Pineyro
Journal:  Mol Pharmacol       Date:  2013-10-30       Impact factor: 4.436

2.  Kir3 channels undergo arrestin-dependant internalization following delta opioid receptor activation.

Authors:  Karim Nagi; Iness Charfi; Graciela Pineyro
Journal:  Cell Mol Life Sci       Date:  2015-04-22       Impact factor: 9.261

3.  The δ-opioid receptor positive allosteric modulator BMS 986187 is a G-protein-biased allosteric agonist.

Authors:  M Alexander Stanczyk; Kathryn E Livingston; Louise Chang; Zara Y Weinberg; Manojkumar A Puthenveedu; John R Traynor
Journal:  Br J Pharmacol       Date:  2019-04-14       Impact factor: 8.739

Review 4.  Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human μ-opioid receptor (OPRM1).

Authors:  Alisa Knapman; Mark Connor
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 5.  Identifying ligand-specific signalling within biased responses: focus on δ opioid receptor ligands.

Authors:  I Charfi; N Audet; H Bagheri Tudashki; G Pineyro
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 6.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

7.  Tolerance to high-internalizing δ opioid receptor agonist is critically mediated by arrestin 2.

Authors:  Ana Vicente-Sanchez; Isaac J Dripps; Alycia F Tipton; Heba Akbari; Areeb Akbari; Emily M Jutkiewicz; Amynah A Pradhan
Journal:  Br J Pharmacol       Date:  2018-06-07       Impact factor: 8.739

8.  In vivo properties of KNT-127, a novel δ opioid receptor agonist: receptor internalization, antihyperalgesia and antidepressant effects in mice.

Authors:  C Nozaki; H Nagase; T Nemoto; A Matifas; B L Kieffer; C Gaveriaux-Ruff
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

9.  The role of regulator of G protein signaling 4 in delta-opioid receptor-mediated behaviors.

Authors:  Isaac J Dripps; Qin Wang; Richard R Neubig; Kenner C Rice; John R Traynor; Emily M Jutkiewicz
Journal:  Psychopharmacology (Berl)       Date:  2016-09-13       Impact factor: 4.530

Review 10.  The delta opioid receptor tool box.

Authors:  Ana Vicente-Sanchez; Laura Segura; Amynah A Pradhan
Journal:  Neuroscience       Date:  2016-06-24       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.